taurolithocholic acid has been researched along with hymecromone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ai, CZ; Cao, YF; Dong, PP; Fang, ZZ; Ge, GB; Gonzalez, FJ; He, RR; Hong, M; Jiang, C; Krausz, KW; Ma, XC; Qi, Y; Sun, HZ; Sun, XY; Tanaka, N | 1 |
1 other study(ies) available for taurolithocholic acid and hymecromone
| Article | Year |
|---|---|
A model of in vitro UDP-glucuronosyltransferase inhibition by bile acids predicts possible metabolic disorders.
Topics: Biocatalysis; Enzyme Inhibitors; Glucuronosyltransferase; Humans; Hymecromone; Intestines; Kinetics; Liver; Metabolic Diseases; Models, Molecular; Protein Conformation; Taurolithocholic Acid; Trifluoperazine | 2013 |